PL2882446T3 - Terapia profilaktyczna i nutraceutyczna - Google Patents

Terapia profilaktyczna i nutraceutyczna

Info

Publication number
PL2882446T3
PL2882446T3 PL13762204T PL13762204T PL2882446T3 PL 2882446 T3 PL2882446 T3 PL 2882446T3 PL 13762204 T PL13762204 T PL 13762204T PL 13762204 T PL13762204 T PL 13762204T PL 2882446 T3 PL2882446 T3 PL 2882446T3
Authority
PL
Poland
Prior art keywords
prophylactic
nutraceutical therapy
nutraceutical
therapy
Prior art date
Application number
PL13762204T
Other languages
English (en)
Inventor
Catharina Svanborg
Manoj PUTHIA
Chin Shing HO
Original Assignee
Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1214237.8A external-priority patent/GB201214237D0/en
Priority claimed from GBGB1214234.5A external-priority patent/GB201214234D0/en
Application filed by Hamlet Pharma Ab filed Critical Hamlet Pharma Ab
Publication of PL2882446T3 publication Critical patent/PL2882446T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13762204T 2012-08-09 2013-08-08 Terapia profilaktyczna i nutraceutyczna PL2882446T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1214237.8A GB201214237D0 (en) 2012-08-09 2012-08-09 Novel therapeutic composition
GBGB1214234.5A GB201214234D0 (en) 2012-08-09 2012-08-09 Prophylactic therapy
EP13762204.9A EP2882446B1 (en) 2012-08-09 2013-08-08 Prophylactic and nutraceutical therapy
PCT/GB2013/052132 WO2014023976A1 (en) 2012-08-09 2013-08-08 Prophylactic and nutraceutical therapy

Publications (1)

Publication Number Publication Date
PL2882446T3 true PL2882446T3 (pl) 2018-10-31

Family

ID=49165779

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13762204T PL2882446T3 (pl) 2012-08-09 2013-08-08 Terapia profilaktyczna i nutraceutyczna

Country Status (8)

Country Link
US (3) US11103561B2 (pl)
EP (2) EP3295953B1 (pl)
DK (2) DK3295953T3 (pl)
ES (2) ES2676543T3 (pl)
HK (1) HK1249855A1 (pl)
HU (1) HUE038910T2 (pl)
PL (1) PL2882446T3 (pl)
WO (1) WO2014023976A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103561B2 (en) 2012-08-09 2021-08-31 Hamlet Pharma Ab Prophylactic and nutraceutical therapy
GB201707715D0 (en) * 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes
CN111494641B (zh) * 2020-04-22 2021-08-03 南开大学 肿瘤微环境响应性的表面电荷可反转纳米药物递送载体
WO2024075003A1 (en) 2022-10-03 2024-04-11 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7792294A (en) 1994-08-16 1996-03-07 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
US7053185B1 (en) 1997-11-21 2006-05-30 Hamlet Pharma Ab Lactalbumin production process
GB0205347D0 (en) 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
EP1727561A1 (en) 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
WO2008058547A2 (en) 2006-11-17 2008-05-22 Nya Hamlet Pharma Ab Alpha-lactalbumin composition
NZ552316A (en) * 2006-12-22 2009-10-30 Fonterra Co Operative Group Dairy product and process
WO2008138348A1 (en) 2007-05-09 2008-11-20 Nya Hamlet Pharma Ab Preparation of complexed lactalbumin
WO2009012784A2 (en) 2007-07-20 2009-01-29 Nya Hamlet Pharma Ab Methods for preparing cytotoxic complexes of emulsifier and fatty acid
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
AU2010204178B2 (en) 2009-01-09 2015-10-29 Hamlet Pharma Ab Complex and production process
WO2010131237A1 (en) 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
WO2012069836A2 (en) * 2010-11-24 2012-05-31 Hamlet Pharma Ab Biologically active complex and its preparation
US11103561B2 (en) 2012-08-09 2021-08-31 Hamlet Pharma Ab Prophylactic and nutraceutical therapy

Also Published As

Publication number Publication date
HUE038910T2 (hu) 2018-12-28
ES2844874T3 (es) 2021-07-23
DK2882446T3 (en) 2018-06-18
EP2882446A1 (en) 2015-06-17
ES2676543T3 (es) 2018-07-20
US11103561B2 (en) 2021-08-31
EP2882446B1 (en) 2018-05-09
HK1249855A1 (zh) 2018-11-16
EP3295953B1 (en) 2020-10-21
EP3295953A1 (en) 2018-03-21
DK3295953T3 (da) 2021-01-25
US20240156916A1 (en) 2024-05-16
US20190282669A1 (en) 2019-09-19
US20150216945A1 (en) 2015-08-06
US11865161B2 (en) 2024-01-09
WO2014023976A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
HK1211475A1 (en) Combination therapy
HK1206666A1 (en) Phototherapy devices and methods
EP2858557A4 (en) IMPROVED REANIMATION
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
HUE042637T2 (hu) Laminátumok és azok elõállítására szolgáló módszerek
HK1210949A1 (en) Combinations and uses thereof
HUE062148T2 (hu) Kódoló eljárások és -berendezések
EP2875014A4 (en) ANTI-MUCUS MEDICAMENTS AND USES THEREOF
GB201217439D0 (en) Combination therapy
EP2931140A4 (en) Tissue repair equipment and methods
HK1198833A1 (en) N-acylpeptide derivatives and their uses n-
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
GB201207305D0 (en) Therapy
HK1210426A1 (en) Combination therapy
HUE038910T2 (hu) Profilaktikus és gyógytáp terápia
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
GB201301571D0 (en) Product and use
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
GB201213778D0 (en) Process and dressng
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
GB201214234D0 (en) Prophylactic therapy
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201218654D0 (en) Methods and product